Technology areas: Biotechnology & Pharmaceuticals • Computing & Software
9 pending office actions • 9 art units • 9 examiners • 0 of 9 (0%) have an AI response strategy ready • 21 patents granted in the last 365 days
University of Tsukuba has 8 pending office actions in Biotechnology & Pharmaceuticals. Each matter is assigned to a distinct examiner and a distinct art unit, producing a fully distributed prosecution profile.
PATEL, JIGNESHKUMAR C is the busiest examiner, with 1 pending office action. Since the listed workload is not concentrated with a recurring examiner, counsel should build matter-specific response plans and maintain a central review of claim terminology.
The art-unit distribution may require different approaches to written description, enablement, and prior-art issues across the portfolio. Consistent internal positions remain useful, but prosecution decisions should follow the record in each application.
Based on the USPTO statutory response window for each pending office action. 5 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 5 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 3 (33%) |
| §102 only | 1 (11%) |
| §112 only | 2 (22%) |
| Multi-statute (no §101) | 3 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| PATEL, JIGNESHKUMAR C | 1 | 79.2% | +21.5% |
| PARK, SOO JIN | 1 | 82.0% | +17.2% |
| NGUYEN, NGHI V | 1 | 53.6% | +50.8% |
| ROZOF, TIMOTHY R | 1 | 72.7% | +23.3% |
| GERMICK, JOHNATHAN R | 1 | 45.7% | +31.3% |
| PALENIK, JEFFREY T | 1 | 53.5% | +27.0% |
| ELKINS, BLAKE HARRISON | 1 | 100.0% | +0.0% |
| XIE, XIAOZHEN | 1 | 56.7% | +65.7% |
| TAKENAKA, RISA | 1 | 26.1% | +100.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 7 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17611007 | NEURAL CELL POPULATION, NEURAL CELL-CONTAINING PREPARATION, AND METHOD FOR PRODUCING SAID POPULATION AND PREPARATION | TAKENAKA, RISA | 6d |
| 18699428 | INFORMATION PROCESSING DEVICE, INFORMATION PROCESSING METHOD, AND PROGRAM | PARK, SOO JIN | 7d |
| 18250121 | COPOLYMER CONTAINING POLY(ETHYLENE GLYCOL) AND POLY(L-AMINO ACID DERIVATIVE), MICROPARTICLES THEREOF AND USE THEREOF IN PHARMACEUTICAL COMPOSITION | PALENIK, JEFFREY T | 22d |
| 19016213 | INFORMATION PROCESSING METHOD, INFORMATION PROCESSING SYSTEM, AND RECORDING MEDIUM | PATEL, JIGNESHKUMAR C | — |
| 18026991 | NERVE FASCICLE AND METHOD OF PRODUCING NERVE FASCICLE | NGUYEN, NGHI V | — |
| 18252819 | FEATURE AMOUNT SELECTION DEVICE, FEATURE AMOUNT SELECTION METHOD, AND PROGRAM | GERMICK, JOHNATHAN R | — |
| 17776191 | EVALUATION DEVICE, EVALUATION METHOD, AND PROGRAM | ELKINS, BLAKE HARRISON | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17611007 | NEURAL CELL POPULATION, NEURAL CELL-CONTAINING PREPARATION, AND METHOD FOR PRODUCING SAID POPULATION AND PREPARATION | TAKENAKA, RISA | 6d |
| 18699428 | INFORMATION PROCESSING DEVICE, INFORMATION PROCESSING METHOD, AND PROGRAM | PARK, SOO JIN | 7d |
| 17772042 | Immune Response Suppressant | XIE, XIAOZHEN | 9d |
| 18250121 | COPOLYMER CONTAINING POLY(ETHYLENE GLYCOL) AND POLY(L-AMINO ACID DERIVATIVE), MICROPARTICLES THEREOF AND USE THEREOF IN PHARMACEUTICAL COMPOSITION | PALENIK, JEFFREY T | 22d |
| 18276762 | BODY TEMPERATURE LOWERING AGENT, BODY TEMPERATURE ELEVATION SUPPRESSOR, FOOD COMPOSITION FOR LOWERING BODY TEMPERATURE,AND FOOD COMPOSITION FOR SUPPRESSING BODY TEMPERATURE ELEVATION | ROZOF, TIMOTHY R | 56d |
| 19016213 | INFORMATION PROCESSING METHOD, INFORMATION PROCESSING SYSTEM, AND RECORDING MEDIUM | PATEL, JIGNESHKUMAR C | — |
| 18026991 | NERVE FASCICLE AND METHOD OF PRODUCING NERVE FASCICLE | NGUYEN, NGHI V | — |
| 18252819 | FEATURE AMOUNT SELECTION DEVICE, FEATURE AMOUNT SELECTION METHOD, AND PROGRAM | GERMICK, JOHNATHAN R | — |
| Art Unit | Apps |
|---|---|
| 2116 | 1 |
| 2675 | 1 |
| 1653 | 1 |
| 1625 | 1 |
| 2122 | 1 |
| 1615 | 1 |
| 1687 | 1 |
| 1674 | 1 |
| 1632 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19016213 | INFORMATION PROCESSING METHOD, INFORMATION PROCESSING SYSTEM, AND RECORDING MEDIUM | PATEL, JIGNESHKUMAR C | 2116 | §101§112 | Non-Final OA | — | Pending | Jan 10, 2025 |
| 18699428 | INFORMATION PROCESSING DEVICE, INFORMATION PROCESSING METHOD, AND PROGRAM | PARK, SOO JIN | 2675 | §102§103§112 | Non-Final OA | 7d | Pending | Apr 08, 2024 |
| 18026991 | NERVE FASCICLE AND METHOD OF PRODUCING NERVE FASCICLE | NGUYEN, NGHI V | 1653 | §102§103§112Other | Final Rejection | — | Pending | Oct 04, 2023 |
| 18276762 | BODY TEMPERATURE LOWERING AGENT, BODY TEMPERATURE ELEVATION SUPPRESSOR, FOOD COMPOSITION FOR LOWERING BODY TEMPERATURE,AND FOOD COMPOSITION FOR SUPPRESSING BODY TEMPERATURE ELEVATION | ROZOF, TIMOTHY R | 1625 | §102 | Final Rejection | 56d | Pending | Aug 10, 2023 |
| 18252819 | FEATURE AMOUNT SELECTION DEVICE, FEATURE AMOUNT SELECTION METHOD, AND PROGRAM | GERMICK, JOHNATHAN R | 2122 | §101§112 | Non-Final OA | — | Pending | May 12, 2023 |
| 18250121 | COPOLYMER CONTAINING POLY(ETHYLENE GLYCOL) AND POLY(L-AMINO ACID DERIVATIVE), MICROPARTICLES THEREOF AND USE THEREOF IN PHARMACEUTICAL COMPOSITION | PALENIK, JEFFREY T | 1615 | §103§112 | Non-Final OA | 22d | Pending | Apr 21, 2023 |
| 17776191 | EVALUATION DEVICE, EVALUATION METHOD, AND PROGRAM | ELKINS, BLAKE HARRISON | 1687 | §101§103 | Final Rejection | — | Pending | May 11, 2022 |
| 17772042 | Immune Response Suppressant | XIE, XIAOZHEN | 1674 | §112 | Non-Final OA | 9d | Pending | Apr 26, 2022 |
| 17611007 | NEURAL CELL POPULATION, NEURAL CELL-CONTAINING PREPARATION, AND METHOD FOR PRODUCING SAID POPULATION AND PREPARATION | TAKENAKA, RISA | 1632 | §112 | Non-Final OA | 6d | Pending | Nov 12, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialUniversity of Tsukuba has 9 pending office actions as of October 2026, spread across 9 art units and 9 examiners.
Jigneshkumar C Patel has the most, with 1 of University of Tsukuba's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
